Allopregnanolone is showing promise as a treatment for Alzheimer’s disease in elderly people and conditions including cerebral palsy in premature infants.
Price Fishback, Takeshi Inomata, Chris Segrin, Kathy Short and Todd Vanderah are the University of Arizona's newest Regents Professors. The university's highest faculty rank honors exceptional achievements that merit national and international recognition.
Comprehensive Pain and Addiction Center researchers are studying how electronic stimulation of the brain can break looping pain signals and destructive cravings.
Nobel Laureate David Julius, PhD, will deliver the keynote address at "Advancing the Neurobiology of Pain – University of Arizona 2023" on March 28.
Dr. Mohab Ibrahim always knew he wanted to be a doctor; his lived experience and mentors helped him find his calling as a pain specialist and researcher.
Interprofessional education modules at the Arizona Simulation Technology and Education Center teach students the importance of teamwork in health care.
Roberta Diaz Brinton, PhD, director of the University of Arizona Center for Innovation in Brain Science (CIBS) will be honored as the Arizona Bioscience Researcher of the Year by the Arizona Bioindustry Association (AZBio) at the 2022 AZBio Awards event Sept. 28 at the Phoenix Convention Center.
The annual event exploring groundbreaking approaches in drug discovery is making an in-person return to Phoenix in September.
More than $20 million in funding from the National Institutes of Health bolsters R. Ken Coit College of Pharmacy’s rise to No. 5.
University of Arizona College of Medicine – Tucson medical students received their white coats representing their future profession on July 29 at Centennial Hall.
Ceremony will honor alumni completing residencies, students receiving medical degrees and students who are preparing to enter medical school in July.
The partnership will advance pain and addiction research and accelerate positive health outcomes in Arizona, Oklahoma and across the country.
Todd Vanderah, PhD, completed his doctorate at the University of Arizona Health Sciences, did his postdoctoral work in Colorado, then returned to a faculty position at the College of Medicine – Tucson, where he is head of the Department of Pharmacology.
Researchers received a $7.6 million grant to investigate PhytoSERM, a supplement that may treat menopausal symptoms and lower Alzheimer’s disease risk.
Tally Largent-Milnes, PhD, is studying the role of the endogenous cannabinoid system in migraine, a neurological disorder that affects women at a higher rate than men.
Fourth-year University of Arizona College of Medicine – Tucson students learned where they’ll launch their careers as new residents.
Arizona leads the nation in enrolling participants in the National Institutes of Health’s All of Us Research Program.
More than 110 College of Medicine – Tucson medical students will simultaneously open envelopes revealing where they will complete their residency training.
College of Medicine – Tucson Class of 2024 medical students will receive their white coats on Feb. 25.
Researchers targeted a common sodium ion channel to reverse pain and saw positive results that could lead to a non-addictive solution to treat pain.
The third annual Drug Discovery and Development Summit aims to foster private-public collaboration and commercialization of new discoveries against diseases most burdensome to Arizonans.
The Comprehensive Pain and Addiction Center will oversee the first peer support experiential learning and apprenticeship program in rural Arizona.
Researchers are studying existing therapies and those in clinical trials to pinpoint the most effective medications for concussion-related headaches.
Researchers in the Comprehensive Pain and Addiction Center have found that terpenes mimic cannabinoids and produce similar pain-relieving effects.
The UArizona College of Medicine – Tucson has accepted six high school graduates in a new program that reduces the time to a medical degree to seven years.